ALTERATIONS IN P53 AND P16(INK4) EXPRESSION AND TELOMERE LENGTH DURING SPONTANEOUS IMMORTALIZATION OF LI-FRAUMENI SYNDROME FIBROBLASTS

被引:0
|
作者
ROGAN, EM
BRYAN, TM
HUKKU, B
MACLEAN, K
CHANG, ACM
MOY, EL
ENGLEZOU, A
WARNEFORD, SG
DALLAPOZZA, L
REDDEL, RR
机构
[1] CHILDRENS MED RES INST,CANC RES GRP,SYDNEY,NSW 2145,AUSTRALIA
[2] ROYAL ALEXANDRA HOSP CHILDREN,CAMPERDOWN,NSW 2050,AUSTRALIA
[3] CHILDRENS HOSP MICHIGAN,CELL CULTURE LAB,DETROIT,MI 48201
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Normal cells have a strictly limited growth potential and senesce after a defined number of population doublings (PDs), In contrast, tumor cells often exhibit an apparently unlimited proliferative potential and are termed immortalized, Although spontaneous immortalization of normal human cells in vitro is an extremely rare event, we observed this in fibroblasts from an affected member of a Li-Fraumeni syndrome kindred, The fibroblasts were heterozygous for a p53 mutation and underwent senescence as expected at PD 40, In four separate senescent cultures (A to D), there were cells that eventually recommenced proliferation, This was associated with aneuploidy in all four cultures and either loss (cultures A, C, and D) or mutation (culture B) of the wild-type (wt) p53 allele. Loss of wt p53 function was insufficient for immortalization, since cultures A, B, and D subsequently entered crisis from which they did not escape. Culture C has continued proliferating beyond 400 PDs and thus appears to be immortalized, In contrast to the other cultures, the immortalized cells have no detectable p16(INK4) protein, A culture that had a limited extension of proliferative potential exhibited a progressive decrease in telomere length with increasing PD. In the culture that subsequently became immortalized, the same trend occurred until PD 73, after which there was a significant increase in the amount of telomeric DNA, despite the absence of telomerase activity, Immortalization of these cells thus appears to be associated with loss of wt p53 and p16(INK4) expression and a novel mechanism for the elongation of telomeres.
引用
收藏
页码:4745 / 4753
页数:9
相关论文
共 50 条
  • [1] P53 AND THE LI-FRAUMENI SYNDROME
    MALKIN, D
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 1994, 1198 (2-3): : 197 - 213
  • [2] P53 AND THE LI-FRAUMENI SYNDROME
    MALKIN, D
    CANCER GENETICS AND CYTOGENETICS, 1993, 66 (02) : 83 - 92
  • [3] Li-Fraumeni syndrome: p53 and beyond
    Wasserman, Jonathan
    Villani, Anita
    Samuel, Nardin
    Merino, Diana
    Novokmet, Ana
    Pienkowska, Margaret
    IdSaid, Badr
    Malkin, David
    CANCER RESEARCH, 2014, 74 (23)
  • [4] Telomerase activity during spontaneous immortalization of Li-Fraumeni syndrome skin fibroblasts
    Gollahon, LS
    Kraus, E
    Wu, TA
    Yim, SO
    Strong, LC
    Shay, JW
    Tainsky, MA
    ONCOGENE, 1998, 17 (06) : 709 - 717
  • [5] Telomerase activity during spontaneous immortalization of Li-Fraumeni syndrome skin fibroblasts
    Lauren S Gollahon
    Eliyahu Kraus
    Tian-Ai Wu
    Sun O Yim
    Louise C Strong
    Jerry W Shay
    Michael A Tainsky
    Oncogene, 1998, 17 : 709 - 717
  • [6] INVOLVEMENT OF RB-1, P53, P16(INK4) AND TELOMERASE IN IMMORTALIZATION OF HUMAN-CELLS
    WHITAKER, NJ
    BRYAN, TM
    BONNEFIN, P
    CHANG, ACM
    MUSGROVE, EA
    BRAITHWAITE, AW
    REDDEL, RR
    ONCOGENE, 1995, 11 (05) : 971 - 976
  • [7] p53 therapy in a patient with Li-Fraumeni syndrome
    Senzer, Neil
    Nemunaitis, John
    Nemunaitis, Michael
    Lamont, Jeffrey
    Gore, Martin
    Gabra, Hani
    Eeles, Rosalind
    Sodha, Nayanta
    Lynch, Frank J.
    Zumstein, Louis A.
    Menander, Kerstin B.
    Sobol, Robert E.
    Chada, Sunil
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (05) : 1478 - 1482
  • [8] P53 GERMLINE MUTATIONS IN LI-FRAUMENI SYNDROME
    SANTIBANEZKOREF, MF
    BIRCH, JM
    HARTLEY, AL
    JONES, PHM
    CRAFT, AW
    EDEN, T
    CROWTHER, D
    KELSEY, AM
    HARRIS, M
    LANCET, 1991, 338 (8781): : 1490 - 1491
  • [9] Li-Fraumeni syndrome - A p53 family affair
    Iwakuma, T
    Lozano, G
    Flores, ER
    CELL CYCLE, 2005, 4 (07) : 865 - 867
  • [10] LI-FRAUMENI SYNDROME AND P53 GERMLINE MUTATIONS
    LEBLANC, T
    SOUSSI, T
    ARCHIVES DE PEDIATRIE, 1994, 1 (01): : 61 - 70